...to $9.5M. Cornerstone also announced it divested its anti-infective assets Factive gemifloxacin mesylate and Spectracef cefditoren pivoxil...

...zileuton were up 16% to $9.3M and 10% to $8.3M, respectively. Sales of antibiotic Spectracef cefditoren pivoxil...

...Italy) and Mexican rights to Pfizer Inc. (NYSE:PFE, New York, N.Y.). Cornerstone already markets Spectracef cefditoren pivoxil...

...HyoMax line of products, which combine four generic antispasmodic medications to treat gastrointestinal disorders, and Spectracef...

...will market Critical's asthma drugs Zyflo immediate-release zileuton and Zyflo CR tablets and Cornerstone's marketed Spectracef...

...company will market Critical's asthma drugs Zyflo immediate-release zileuton and Zyflo CR tablets and Cornerstone's Spectracef...

...The FDA granted marketing approval for Tap's Spectracef cephalosporin antibiotic to treat acute exacerbations of chronic...
...antibiotic to treat acute exacerbations of chronic bronchitis, pharyngitis/tonsillitis, and uncomplicated skin infections. Tap licensed Spectracef...
...Seika Kaisha Ltd. (Tokyo, Japan). Tap Pharmaceutical Products Inc. , Lake Forest, Ill. Product: Spectracef cefditoren pivoxil...

...The FDA granted marketing approval for Spectracef cefditoren pivoxil from Tap Pharmaceutical (Lake Forest, Ill.) to treat...
...Ill.) to treat acute exacerbations of chronic bronchitis, pharyngitis/tonsillitis and uncomplicated skin infections. Tap licensed Spectracef...

...TAP said the clinical cure rates for evaluable patients receiving 200 and 400 mg of Spectracef...
...from Meiji Seika Kaisha Ltd. (Tokyo, Japan). TAP Pharmaceuticals Inc., Lake Forest, Ill. Product: Spectracef cefditoren pivoxil...

...TAP Pharmaceuticals (Deerfield, Ill.) said that in a Phase III study of its Spectracef cefditoren pivoxil oral...
...equivalence between cefditoren and clarithromycin. In January, TAP submitted an NDA to the FDA for Spectracef...